Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Herbal tea combo tested for stomach relief

NCT ID NCT06628804

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether taking artemisia and green tea extracts for 8 weeks can improve stomach health in adults with functional dyspepsia (indigestion without a clear cause). 100 participants were randomly assigned to receive the extracts or a placebo. The main goal was to see if symptoms like pain and bloating improved, and to check for side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Aug 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Rome IV-based functional dyspepsia- Exclusion Criteria: * Patients with gastrointestinal symptoms requiring immediate drug treatment. * Individuals with a history of hypersecretory gastric disorders like Zollinger-Ellison syndrome. * Individuals who received Helicobacter pylori eradication therapy within 4 weeks prior to the trial. * Individuals who have taken nonsteroidal anti-inflammatory drugs, steroids, antibiotics, aspirin, antithrombotic agents, or acid suppressants within the last month. * Individuals with a history of upper gastrointestinal surgery, stricture, bleeding, or procedures like esophageal dilation or mucosal resection within the last year. * Individuals with gastric ulcers (active or healing), duodenal ulcers (active or healing), reflux esophagitis (LA grade A or higher), or malignant tumors identified within the last 6 months through endoscopy. * Patients with uncontrolled hypertension (resting BP ≥160/100 mmHg). * Patients with uncontrolled diabetes (fasting glucose ≥160 mg/dL). * Individuals with creatinine levels ≥ 2 times the upper limit of normal at the research institution. * Individuals with aspartate aminotransferase or alanine aminotransferase levels ≥ 2 times the upper limit of normal at the research institution. * Alcohol abusers. * Individuals taking medications for psychiatric disorders (except those taking intermittent medication for sleep disorders). * Pregnant or breastfeeding women or those planning to become pregnant during the clinical trial period. * Individuals with allergies to any components of the study foods. * Individuals who participated in or plan to participate in another drug clinical trial within the last month. * Individuals deemed unsuitable for the study by the investigator for other reasons.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Functional dyspepsia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Pusan National University Yangsan Hospital

    Yangsan, 50612, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.